The Influence of Age Advancement and of Comorbidities on the Functional Capacity of Patients After the Incident of Ischemic Stroke
DOI:
https://doi.org/10.15225/PNN.2015.4.3.2Keywords
stroke, functional capacity, risk factorsAbstract
Introduction. The occurrence of ischemic strokes, particularly with people over 65 years of age, results from the presence of comorbidities that may adversely affect both the early and late prognosis as well as functional capacities of patients.
Aim. The aim of the study was to evaluate the efficiency regarding basic daily activities performed by patients after the incident of the ischemic stroke, depending on the advancement of their age and the on the presence of comorbidities.
Material and Methods. The study was carried out among 65 patients hospitalised due to the ischemic stroke in the neurology ward of the Provincial Hospital in Plock. The analysis of the functional capacity of patients, with the use of the Barthel Scale Questionnaire, was performed twice: on the first day of their hospitalisation and on the day of discharge from the hospital ward.
Results. The functional capacity of the patients within the period of hospitalization after the incident of ischemic stroke was improving as a result of treatment, rehabilitation and care. However, both on the day of admission to the ward, as well as at discharge, the patients aged over 65 had the lowest scores on the Barthel Scale Questionnaire. The presence of comorbidities, particularly among older respondents, contributed to the deterioration of patients’ functional capacity.
Conclusions.
1). Patients after the incident of ischemic stroke, despite the improvement regarding their functional capacity, require assistance in the performance of daily activities.
2). Age advancement contributes to the reduction of the functional capacity of respondents after the incident of ischemic stroke.
3). Comorbidities of the incident of ischemic stroke as well as the prior episode of stroke significantly contribute to the decrease the functional capacity of respondents.
(JNNN 2015;4(3):102–108)
References
Hankey G.J., Warlow C.P. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet. 1999;354: 1457-1463.
Wolfe CD. The impact of stroke. Br Med. Bull. 2000;56(2):275-286.
Ryglewicz D., Milewska D. Epidemiologia udaru mózgu. In Mazur R., Książkiewicz B., Nyka W.M. (Red.), Udar mózgu w praktyce lekarskiej. Via Medica, Gdańsk 2010;5–14.
Mazur R., Świerkocka-Miastkowska M. Udar mózgu – pierwsze objawy. Choroby Serca i Naczyń. 2005;2(2): 84–87.
Nowacki P., Bajer-Czajkowska A. Profilaktyka wtórna niedokrwiennego udaru mózgu w świetle medycyny opartej na dowodach. Polski Przegląd Neurologiczny. 2008;4(3):147–152.
Strepikowska A., Buciński A. Udar mózgu – czynniki ryzyka i profilaktyka. Postępy Farmakoterapii. 2009;65(1):46–50.
Biller J., Love B. Choroby naczyniowe układu nerwowego. In Prusiński A. Neurologia w praktyce klinicznej. Wydawnictwo Czelej, Lublin 2006;1430,1444,1483.
Schwamm L.H., Pancioli A., Acker III J.E. et al. Recommendations
for the establishment of stroke systems of care: recommendations from the American Stroke Association’s Task Force on the Development of Stroke Systems. Stroke. 2005;36(3):690-703.
Rynkiewicz M., Rogulska U., Czernicki J. Ocena zmian sprawności funkcjonalnej osób we wczesnym okresie po udarze mózgu. Przegląd Medyczny Uniwersytetu Rzeszowskiego i Narodowego Instytutu Leków w Warszawie. 2011;(2):325–339.
Trochimiuk J, Kochanowski J, Stolarski J, Wójtowicz S. Efekty wczesnej rehabilitacji w okresie pobytu szpitalnego pacjentów z udarem niedokrwiennym mózgu. Rehabilitacja w praktyce. 2009;(4):15-19.
Jaracz K, Kozubski W. Jakość życia po udarze mózgu. Część I – badania prospektywne. Udar Mózgu. 2001;3(2):55-62.
Hirtz D., Thurman D.J., Gwinn-Hardy K. et al. How common are the „common” neurologic disorders. Neurology. 2007;(68):326-337.
Truelsen T, Piechowski-Jóźwiak B, Bonita R. et al. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol. 2006;13(6):581-598.
Grabowska-Fudala B., Jaracz K., Górna K. Zapadalność, śmiertelność i umieralność z powodu udarów mózgu – aktualne tendencje i prognozy na przyszłość. Przegląd Epidemiologiczny. 2010;(64):439–442.
Główny Urząd Statystyczny. Prognoza ludności na lata 2014 – 20150. Zakład Wydawnictw Statystycznych, Warszawa, 2014.
Wawrzyniak S., Wawrzyniak K. Wpływ wybranych czynników społeczno-demograficznych na przebieg udaru niedokrwiennego mózgu. Udar Mózgu. 2006;8(1):s.22-27.
Bartoszek A., Siemko E., Kachaniuk H., Kocka K., Stanisławek A. Analiza czynników określających poziom wydolności samoobsługowej pacjentów oddziału neurologii. Medycyna Ogólna i Nauki o Zdrowiu.;19(2):147-150.
Goldstein L.B., Adams R., Alberts M.J. et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary
Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity,and Metabolism Council; and the
Quality of Care and Outcomes Research Interdisciplinary Working Group. Stroke. 2006;37:1583-633.
Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;(22):983–988.
Kissela B.M.., Khoury J., Kleindorfer D. et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care. 2005:28(2):355-9.
Schmidt EV, Smirnov VE, Ryabova VS. Results of the seven year prospective study of stroke patients. Stroke. 1988;19:942-949.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 142
Number of citations: 0